-
First-trimester screening for neural tube defects using alpha-fetoprotein.
Bredaki FE, Poon LC, Birdir C, Escalante D, Nicolaides KH.
Fetal Diagn Ther 2012;31:109-14. -
Maternal serum ferritin at 11- to 13-week gestation in spontaneous early preterm delivery.
Beta J, Poon LC, Bakalis S, Mosimann B, Nicolaides KH.
J Matern Fetal Neonatal Med 2012;25:1852-5. -
Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidies.
Ball S, Wright D, Sodre D, Lachmann R, Nicolaides KH.
Fetal Diagn Ther 2012;31:162-9. -
C-reactive protein at 11-13 weeks' gestation in spontaneous early preterm delivery.
Bakalis SP, Poon LC, Vayna AM, Pafilis I, Nicolaides KH.
J Matern Fetal Neonatal Med 2012;25:2475-8. -
Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors.
Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH.
Fetal Diagn Ther 2012;31:237-43. -
Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.
Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH.
Am J Obstet Gynecol 2012;206:322. -
Normal range of maternal serum vitamin D at 11-13 weeks gestation.
Yu CK, Ertl R, Samaha R, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2011;30:94-9. -
Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model.
Wright D, Syngelaki A, Staboulidou I, Cruz JJ, Nicolaides KH.
Prenat Diagn 2011;31:16-21. -
First-Trimester Screening for Trisomy 21 with Adjustment for Biochemical Results of Previous Pregnancies.
Wright D, Syngelaki A, Birdir C, Bedei I, Nicolaides KH.
Fetal Diagn Ther 2011;30:194-202. -
The duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction.
Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat AA.
Ultrasound Obstet Gynecol 2011;38:295-302. -
Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks.
Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH.
Prenat Diagn 2011;31:90-102. -
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
Prevalence and Outcome of Absence of Ductus Venosus at 11 to 13(+6) Weeks.
Staboulidou I, Pereira S, Cruz JJ, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2011;30:35-40. -
Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Prenat Diagn 2011;31:196-201. -
Maternal serum human placental growth hormone (hPGH) at 11 to 13 weeks of gestation in preeclampsia.
Sifakis S, Akolekar R, Mantas N, Kappou D, Nicolaides KH.
Hypertens Pregnancy 2011;30:74-82. -
Maternal serum IGF-I, IGFBP-1 and IGFBP-3 at 11-13 weeks in trisomy 21 and trisomy 18 pregnancies.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 2011;157:166-8. -
Maternal arterial stiffness in women who subsequently develop pre-eclampsia.
Savvidou MD, Kaihura C, Anderson JM, Nicolaides KH.
PLoS One 2011;6:e18703. -
First trimester maternal uterine artery Doppler examination in HIV-positive women.
Savvidou M, Samuel M, Akolekar R, Poulton M, Nicolaides K.
HIV Med 2011;12:632-6. -
Maternal serum 25-hydroxyvitamin D levels at 11(+0) -13(+6) weeks in pregnant women with diabetes mellitus and in those with macrosomic neonates.
Savvidou M, Akolekar R, Samaha R, Masconi A, Nicolaides Kh.
BJOG 2011;118:951-5. -
First-trimester markers of aneuploidy in women positive for HIV.
Savvidou M, Samuel I, Syngelaki A, Poulton M, Nicolaides K.
BJOG 2011;118:844-8.